Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
This study is designed to investigate the safety and efficacy of the combination of imatinib
and vinorelbine in patients with advanced, anthracycline resistant breast cancer